High materiality7/10
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald reiterates overweight rating; target $21 vs posted price $14.24; priceChangeSinceSignal -0.69.
- Target: $21
- Posted price: $14.24
- Analyst firm: Raymond James
- Analyst: Sarah James
Key facts
- 01
Target: $21
- 02
Posted price: $14.24
- 03
Analyst firm: Raymond James
- 04
Analyst: Sarah James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.